Rudi Pauwels
Rudi Pauwels | |
|---|---|
Dr. Rudi Pauwels | |
| Born | 1960 |
| Nationality | Belgian |
| Education | Ph.D. in pharmaceutical sciences |
| Alma mater | KU Leuven |
| Occupation(s) | Pharmaceutical scientist and biotech entrepreneur |
| Organization(s) | Praesens Foundation, Praesens Care, miDiagnostics |
| Awards | Prix Galien MedStartUpAward (2019), Global Technology Pioneer Award (2012), INSEAD Innovator Prize (2002) |
Rudi Pauwels (born 1960) is a Belgian pharmacologist and biotech entrepreneur.
He was one of the first researchers in the field of HIV, and he played a key role in the fight against the AIDS pandemic by discovering several widely used anti-HIV drugs during his doctorate studies at the Rega Institute (Leuven, Belgium) and while leading biotech companies Tibotec and Virco.
Since 1994 he has either founded or co-founded several biotech companies, specialising in personalized and high precision medicine. His current roles include founder and president of the Praesens Foundation, chairman of Praesens Care, executive chairman of IMEC/Johns Hopkins spin-off company miDiagnostics and board positions in various companies and research institutes. He is an author of more than 150 peer-reviewed papers and recipient of numerous awards and distinctions.
In 2020 he was appointed as co-chair of the Diagnostics R&D Working Group of the Access to COVID-19 Tools Accelerator.